Clinical Trial of Efcid (Himcocid) in Patients of Acid Peptic Disease

Fifty patients in the age group of 18-60 years from the medical wards of Bowring and Lady Curzon Hospital were enrolled for the study. Out of 50 patients 30 were males and 20 were females. All the patients were subjected to upper gastrointestinal evaluation by endoscopy except for 3 patients who did not agree to undergo endoscopic evaluation. The diagnosis was based on clinical symptoms and endoscopic findings. Of the 47 patients who underwent endoscopic examination, 31 had gastritis with reflux esophagitis, 11 had peptic ulcers and 5 had portal hypertensive gastropathy with oesophageal varices. Efcid syrup was given to all the patients at a dose of 10-15 ml thrice daily for a period of 4 weeks. The drug was well tolerated and there were no adverse effects. In all the 50 patients the response was good with significant symptomatic relief. A majority of the patients were on monotherapy, only Efcid syrup.